Carotid Stents Market Growth, Demand & Size by 2034

Carotid Stents Market Size and Forecasts (2021–2034), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage:by Type (Balloon-Expandable Stents, Self-Expanding Stents); Material (Metals, Others Stents); End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024   |   Base Year: 2025   |   Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00008521
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
Carotid Stents Market Growth, Demand & Size by 2034
Report Date: Aug 2026   |   Report Code: TIPRE00008521 Email: sales@theinsightpartners.com
Buy Now

The Carotid Stents Market size is expected to reach US$ 8.87 Billion by 2034 from US$ 4.34 Billion in 2025. The market is estimated to record a CAGR of 8.26% from 2026 to 2034.

The report is segmented By Type (Balloon-Expandable Stents, Self-Expanding Stents); Material (Metals, Others Stents); End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Carotid Stents Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Carotid Stents Market Segmentation

Type

  1. Balloon-Expandable Stents
  2. Self-Expanding Stents

Material

  1. Metals
  2. Others Stents

End User

  1. Hospitals
  2. Cardiac Centers
  3. Ambulatory Surgical Centers

Geography

  1. North America
  2. Europe
  3. Asia-Pacific
  4. South and Central America
  5. Middle East and Africa

Market Research Highlights

  • Global market for Carotid Stents was valued at US$ 4.34 Billion in 2025
  • Annual market size is expected to reach US$ 8.87 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 59.31 Billion
  • Market is anticipated to register a CAGR of 8.26% during the forecast period
  • The United States represents a key market, supported by Rising Incidence of Cardiovascular Diseases, Advancement in stenting technology, Rising Awareness and Screening Programs, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Expansion into Emerging Markets, Development of Novel Stenting Technologies, Collaborative Research and Clinical Trials are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Abbott, Boston Scientific Corporation, CeloNova BioSciences, Inc., Cook Group, Cordis (Cardinal Health), InspireMD Inc., Medtronic, MicroPort Scientific Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., while analyzing competitive strategies and innovation developments

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Carotid Stents Market: Strategic Insights

carotid-stents-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Carotid Stents Market Growth Drivers

  1. Rising Incidence of Cardiovascular Diseases: One of the major drivers for the carotid stents market is the growing number of cardiovascular diseases, majorly carotid artery stenosis. Since the causes for most of these diseases are lassitude in diet, obesity, and other sedentary behavior, it increases the demand for an efficient treatment. Carotid stenting is a minimally invasive cure for the patients, so it is the most preferred treatment by the patients as well as the healthcare practitioners.
  2. Advancement in stenting technology: The carotid stents market is highly influenced by technological advances in the stenting procedures themselves. The main drivers here are drug-eluting stents and delivery systems. These technologies have made the procedures safer and effective, diminishing complications and recovery time. Therefore, healthcare providers can widely adopt carotid stenting as a routine treatment given the availability of new technologies.
  3. Rising Awareness and Screening Programs: Growing awareness of carotid artery diseases and preventive screening programs has led to a huge demand for carotid stents. Educational initiatives toward healthcare professionals as well as toward the general public are oriented around the importance of early detection and treatment. As more and more people are undergoing routine screening and made aware of the availability of treatment, the carotid stent market is bound to mushroom very significantly.

Carotid Stents Market Future Trends

  1. Shift Toward Minimally Invasive Procedures: The market for carotid stents is increasingly shifting towards more minimally invasive procedures. Stenting is favored in place of traditional open surgery due to fewer recovery times, less time in the hospital, and a lower chance of complications by patients as well as their healthcare providers. This trend motivates more medical facilities to embrace carotid stenting as an ordinary treatment for carotid artery stenosis, which, in turn, boosts market growth.
  2. Improvement of Advanced Imaging Technologies: Advances in 3D angiography and intravascular ultrasound revolutionize the carotid stents market. They enhance the pre-procedure planning and real-time guidance during stenting with respect to accuracy in procedures and better patient outcomes. Increasingly, more clinicians use the equipment, resulting in rising effectiveness in carotid stenting, adoption rates increase and also increases patient satisfaction.
  3. Emphasis on Personalized Medicine: The growing emphasis of personalized medicine impacts the carotid stents market. Instead of relying upon general, profile-based treatments, specific options in stenting are chosen for the consideration of age, comorbidities as an individual condition, and genetic predispositions. With improvement on both counts-in treatment efficacy and patient empowerment and adherence-neater clinical results translate to better market growth.

Carotid Stents Market Opportunities

  1. Expansion into Emerging Markets: The market for carotid stents throws much opportunity in developing economies where the medical structure is being advanced day by day. As awareness regarding cardiovascular diseases increases and the access to advanced medical technologies opens up, the demand for carotid stenting is going to increase proportionally. Companies can exploit this opportunity through providing effective, high-quality stenting solutions at suitable prices to cater to the needs of these markets.
  2. Development of Novel Stenting Technologies: Carotid stents market have an exclusive opportunity for innovation through novel stenting technologies. Technologies, including biodegradable stents and drug eluting, can further improve the effectiveness of treatment and reduce the risk of restenosis. Investment in research and development could be a way through which companies different products as needs of healthcare providers and patients will keep on changing.
  3. Collaborative Research and Clinical Trials: The collaborative research and clinical trials with healthcare institutions. In the context of the carotid stents market, this is a huge opportunity, as these will facilitate evidence-based solutions and validate new products in a real-world clinical setting. This collaboration does not only add credibility but also accelerates the adoption of innovative stenting technologies for propulsion in growth.

Carotid Stents Market Report Scope

Report Attribute Details
Market size in 2025 US$ 4.34 Billion
Market Size by 2034 US$ 8.87 Billion
Global CAGR (2026 - 2034) 8.26%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Type
  • Balloon-Expandable Stents
  • Self-Expanding Stents
By Material
  • Metals
  • Others Stents
By End User
  • Hospitals
  • Cardiac Centers
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott
  • Boston Scientific Corporation
  • CeloNova BioSciences, Inc.
  • Cook Group
  • Cordis (Cardinal Health)
  • InspireMD Inc.
  • Medtronic
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

Carotid Stents Market Players Density: Understanding Its Impact on Business Dynamics

The Carotid Stents Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

carotid-stents-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Carotid Stents Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Carotid Stents Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

rising incidence of cardiovascular diseases and advancement in stenting technology are the major factors boosting the carotid stents market growth

Abbott, Boston Scientific Corporation, CeloNova BioSciences, Inc, Cook Group, Cordis (Cardinal Health), InspireMD Inc, Medtronic, MicroPort Scientific Corporation, Terumo Corporation, W. L. Gore & Associates, Inc. are the some of the key market players operating in the carotid stents market

The market is expected to grow at a CAGR of 8.26% from 2026 to 2034

The final report will duly include market size with CAGR of 8.26% from 2026 to 2034

The North America region accounts for highest revenue share carotid stents market

Asia Pacific is estimated to grow at the highest CAGR of 8.26% from 2026 to 2034
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
☀️ Eligible for Summer Discount
Unlock Exclusive Report Discounts
Enquire Now
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
ISO Certified Logo
GDPR
CCPA
Page Updated: Apr 2026